Page 90 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 90

CHAPTER 3  The Pathology of Neoplasia  69



            TABLE 3.5     Molecular Features Underlying Grading   has been shown to be a sensitive alternative to histopathology for
                       Criteria                                  LN metastasis needed for staging. 85,86  However, if the cytologic
                                                                 assessment is negative, histologic evaluation still should be consid-
  VetBooks.ir  Grading Criteria  Underlying Molecular Mechanisms  ered. In both processes of tumor grading or tumor staging, these
                                                                 procedures are useful only if they have been shown to correlate
                          Cyclins, cyclin-dependent kinases (CDKs),
             Mitotic activity
                            proliferating cell nuclear antigen (PCNA), Ki67,   with clinical behavior. 
                            bromodeoxyuridine (BrdUrd), labeling index (LI)/
                            growth fraction (GF)                 Assessment of Tumor Margins
             Percent necrosis  Inflammatory mediators, including eicosanoids
                            (prostaglandins), cytokines; microvessel density   Margin assessment is an essential component of oncologic
                            (MVD), including vascular endothelial growth   specimen review, especially when the surgical goal is curative-
                            factor (VEGF), thrombospondin-1 (TSP-1), and   intent. 1,87  Although several important limitations are associated
                            hypoxia-inducible factor 1-α         with this practice, routine histopathology is the most widely
                                                                 available method of determining excisional completeness. His-
             Invasiveness  Matrix metalloproteinases (MMPs), plasminogen
                            activators (PA), integrin expression, cell adhesion   tologic margins are a predictive marker of surgical treatment;
                            molecules (E-cadherin, N-cadherin)   however, margin status does not predict recurrence with absolute
                                                                 certainty. 1,87,88  Additionally, margin status at a primary site does
             Stromal      Transforming growth factor beta (TGF-β), platelet-  not address the potential for metastases or the likelihood of a
               reaction     derived growth factor (PDGF), basic fibroblast   disease-free state.
                            growth factor (bFGF), VEGF, MVD mediators
                                                                   The surgical edge refers to the surgically incised edge/excisional
             Nucleolar size  RNA transcriptional activity, silver staining nucleolar   edge of the biopsy specimen. The gross surgical margin refers to
                            organizing regions (AgNORs)          the region between the surgical edge and the physically palpable
                                                                 and/or visual mass; typically determined before the surgical pro-
             Overall      Growth fraction, apoptosis factors (i.e., FasL,
               cellularity  caspases), tumor doubling time       cedure and presumed to be tumor free. Microscopically the histo-
                                                                 logic surgical margin (histologic tumor-free margin [HTFM]) is
                                                                 the quantifiable tumor-free tissue between the neoplastic process
                                                                 and the surgically incised edge. Microscopic margin assessment
           typically co-occur and, similarly, morphologic grading criteria are   should be performed for both benign and malignant lesions,
           likely interconnected (e.g., tumoral necrosis, inflammation, stro-  although detailed characterization of the HTFM (e.g., objective
           mal response, and invasive growth). 46                measurement,  tissue constituents and viability)  may be limited
             As digital technologies become more readily available, grading   to malignancies because recurrence of benign tumors is uncom-
           schemes may change. Digitization has the potential to transform   mon. Crucial determinants for obtaining accurate surgical margin
           previously categorical morphologic criteria into more objective   information on the pathology report are (1) specimen handling
           and repeatable continuous variables; it also will help assess the   and information submitted by the clinician; (2) the method of
           value of individual morphologic criteria used to estimate the prog-  tissue trimming performed at the laboratory; and (3) observations
           nosis. 76–78  Automated computerized morphologic examination is   reported by the pathologist. 1
           not routinely available in veterinary diagnostic pathology, but it   Histologic surgical margins should be interpreted with a
           might soon overcome the current limitations.          knowledge of the intrinsic limitations of histopathology and fac-
             Grading may be supplemented by ancillary diagnostics to pro-  tors that influence the pathologist’s interpretation. The clinician
           vide a more accurate prognostic estimate. For example, internal   is responsible for communicating the surgical goals as they relate
           tandem duplications in exon 11 of the c-kit proto-oncogene have   to excisional outcomes (i.e., debulking versus curative-intent) and
           been linked to tumor grade, survival, and response to tyrosine   which tissue edges require microscopic scrutiny. In some cases
           kinase inhibitor therapies. 79–82  Measures of tumor growth fraction   annotated sketches or images might assist with trimming (regions
           (e.g., Ki67 index) have been successfully applied to canine oral   selected from the gross specimen at the laboratory for processing
           melanocytic tumors, particularly when routine morphologic inter-  and microscopic evaluation). Inking is the preferred method of
                                                            83
           pretation offers an ambiguous assessment of the biologic course.    identifying a surgical edge because it can be visualized at both the
           Recognition of cancer stem cells and an enhanced knowledge of   gross and microscopic levels. 5,89  Grossly the surgical ink affects
           tumor heterogeneity may continue to influence approaches to   regions of the specimen that are selected during trimming for
           tumor grading.                                        microscopic examination. Importantly, ink allows the pathologist
             The pathologist may assist in staging by assessing tumor size,   to identify a true surgical edge appropriately under the microscope
           depth of invasion, LN involvement, or confirmation of the neo-  (as opposed to artifact) and report the margin as it relates to a
           plastic process at distant sites. This information is needed to stage   specific gross anatomic region. Surgical ink should be placed only
           tumors into WHO’s TNM system (i.e., tumor size and/or inva-  on regions of the specimen that are true surgically incised edges
           sion; nodal involvement; and distant metastasis).  Categories for   or areas of specific clinical concern. Ink should also be allowed to
                                                14
           tumor size and depth of invasion vary according to tumor type.   dry according to the manufacturer’s instructions (approximately
           In human melanoma the Clark and Breslow scales are used to   15 minutes) before fixative immersion. Even under ideal condi-
           determine tumor size and depth of skin involvement. In human   tions, inking can be associated with a number of artifacts that may
           bladder cancer, tumor staging is largely based on the depth of   influence the histologic interpretation.  Continuous suturing of
                                                                                               90
                                        3,5
           tumor invasion into the bladder wall.  Similar concepts might   postexcisional specimens might mitigate artifacts associated with
           be applicable for veterinary patients with tumors such as canine   tissue alignment and cohesion. 91
           urothelial carcinoma and feline gastrointestinal lymphoma. 10,84    Histologic surgical margin outcomes are influenced by the
           Cytologic assessment (i.e., fine-needle aspirate) of draining LNs   method used to trim specimens at the laboratory. 1,92,93  One study
   85   86   87   88   89   90   91   92   93   94   95